TNFRSF11B and inflammatory bowel disease: In what appears to be an attempt to maintain bone homeostasis, the decoy RANK receptor, osteoprotegerin (OPG), which inhibits osteoclastogenesis, has been found to be elevated in the plasma of IBD patients [21].